These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26055418)

  • 1. Immunosuppression and Chagas disease; experience from a non-endemic country.
    Salvador F; Sánchez-Montalvá A; Valerio L; Serre N; Roure S; Treviño B; Pou D; Sulleiro E; Bocanegra C; Molina I
    Clin Microbiol Infect; 2015 Sep; 21(9):854-60. PubMed ID: 26055418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile.
    Salvador F; Treviño B; Sulleiro E; Pou D; Sánchez-Montalvá A; Cabezos J; Soriano A; Serre N; Gómez I Prat J; Pahissa A; Molina I
    Clin Microbiol Infect; 2014 Jul; 20(7):706-12. PubMed ID: 24329884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain.
    Ramos JM; Torrús D; Amador C; Jover F; Pérez-Chacón F; Ponce Y; Arjona FJ; Caro E; Martínez-Peinado C; Gallegos I; Cuadrado JM; Tello A; Gutiérrez F
    Pathog Glob Health; 2012 Oct; 106(6):340-5. PubMed ID: 23182138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression and Chagas disease: a management challenge.
    Pinazo MJ; Espinosa G; Cortes-Lletget C; Posada Ede J; Aldasoro E; Oliveira I; Muñoz J; Gállego M; Gascon J
    PLoS Negl Trop Dis; 2013; 7(1):e1965. PubMed ID: 23349998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chagas disease in the immunosuppressed patient.
    Lattes R; Lasala MB
    Clin Microbiol Infect; 2014 Apr; 20(4):300-9. PubMed ID: 24602129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain).
    Muñoz J; Gómez i Prat J; Gállego M; Gimeno F; Treviño B; López-Chejade P; Ribera O; Molina L; Sanz S; Pinazo MJ; Riera C; Posada EJ; Sanz G; Portús M; Gascon J
    Acta Trop; 2009 Jul; 111(1):51-5. PubMed ID: 19426663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.
    Rumi MM; Pérez Brandán C; Gil JF; D'Amato AM; Ragone PG; Lauthier JJ; Tomasini N; Cimino RO; Orellana V; Lacunza CD; Nasser JR; Basombrío MA; Diosque P
    Acta Trop; 2013 Oct; 128(1):130-6. PubMed ID: 23880286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres.
    Crespillo-Andújar C; López-Vélez R; Trigo E; Norman F; Díaz-Menéndez M; Monge-Maillo B; Arsuaga M; Pérez-Molina JA
    Clin Microbiol Infect; 2020 Mar; 26(3):384.e1-384.e4. PubMed ID: 31740423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.
    Jardim E; Takayanagui OM
    J Trop Med Hyg; 1994 Dec; 97(6):367-70. PubMed ID: 7966540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.
    Murcia L; Carrilero B; Muñoz MJ; Iborra MA; Segovia M
    J Antimicrob Chemother; 2010 Aug; 65(8):1759-64. PubMed ID: 20542903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chagas disease in Italy: breaking an epidemiological silence.
    Angheben A; Anselmi M; Gobbi F; Marocco S; Monteiro G; Buonfrate D; Tais S; Talamo M; Zavarise G; Strohmeyer M; Bartalesi F; Mantella A; Di Tommaso M; Aiello Kh; Veneruso G; Graziani G; Ferrari M; Spreafico I; Bonifacio E; Gaiera G; Lanzafame M; Mascarello M; Cancrini G; Albajar-Vinas P; Bisoffi Z; Bartoloni A
    Euro Surveill; 2011 Sep; 16(37):. PubMed ID: 21944554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina.
    Cura CI; Lucero RH; Bisio M; Oshiro E; Formichelli LB; Burgos JM; Lejona S; Brusés BL; Hernández DO; Severini GV; Velazquez E; Duffy T; Anchart E; Lattes R; Altcheh J; Freilij H; Diez M; Nagel C; Vigliano C; Favaloro L; Favaloro RR; Merino DE; Sosa-Estani S; Schijman AG
    Parasitology; 2012 Apr; 139(4):516-21. PubMed ID: 22309735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Chagas disease in Europe: 45 cases from Spain and Switzerland.
    Rodriguez-Guerineau L; Posfay-Barbe KM; Monsonis-Cabedo M; Juncosa-Morros T; Diana A; Wyler-Lazarevic CA; de Tejada BM; Chappuis F; Fumadó-Pérez V; Jackson Y
    Pediatr Infect Dis J; 2014 May; 33(5):458-62. PubMed ID: 24153010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients.
    Salvador F; Sulleiro E; Sánchez-Montalvá A; Martínez-Gallo M; Carrillo E; Molina I
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004663. PubMed ID: 27115603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
    Carrilero B; Murcia L; Martínez-Lage L; Segovia M
    Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical and epidemiological study of the Trypanosoma cruzi infected population in the north metropolitan area of Barcelona].
    Valerio-Sallent L; Roure S; Basile L; Ballesteros LA; Sabrià M; Rodrigo C;
    Rev Clin Esp; 2012 Jul; 212(7):329-36. PubMed ID: 22608192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation.
    Burgos JM; Diez M; Vigliano C; Bisio M; Risso M; Duffy T; Cura C; Brusses B; Favaloro L; Leguizamon MS; Lucero RH; Laguens R; Levin MJ; Favaloro R; Schijman AG
    Clin Infect Dis; 2010 Sep; 51(5):485-95. PubMed ID: 20645859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis.
    Pérez-Molina JA; Pérez-Ayala A; Moreno S; Fernández-González MC; Zamora J; López-Velez R
    J Antimicrob Chemother; 2009 Dec; 64(6):1139-47. PubMed ID: 19819909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of Chagas disease by immunosuppressive therapy in a patient with systemic lupus erythematosus: report of an exceptional case.
    Burgos LG; Ortiz BD; Canese A; Ojeda A; Melo M
    Am J Dermatopathol; 2012 Aug; 34(6):e84-9. PubMed ID: 22814327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report of a family outbreak of Chagas disease in French Guiana and posttreatment follow-up.
    Blanchet D; Brenière SF; Schijman AG; Bisio M; Simon S; Véron V; Mayence C; Demar-Pierre M; Djossou F; Aznar C
    Infect Genet Evol; 2014 Dec; 28():245-50. PubMed ID: 25448161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.